Clinical Trial

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-01-18; most recent amendment 2025-07-01.
Status change: Not Yet Recruiting → Recruiting 2024-08-11
Trial Details
NCT Number NCT06228079
Lead Sponsor Eye & ENT Hospital of Fudan University
Collaborators: Shanghai Zhongshan Hospital, Shanghai 6th People's Hospital, Changhai Hospital, Fujian Medical University Union Hospital, People's Hospital of Guangxi Zhuang Autonomous Region, Shenzhen Second People's Hospital
Conditions Recurrent Nasopharyngeal Carcinoma
Enrollment 176 participants
Start Date 2024-06-25
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-04